JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB47997

Anti-TIM 3 antibody

4

(2 Reviews)

|

(10 Publications)

Goat Polyclonal TIM 3 antibody. Suitable for WB, Flow Cyt, ICC/IF and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human HAVCR2 aa 200-250.

View Alternative Names

CD366, TIM3, TIMD3, HAVCR2, Hepatitis A virus cellular receptor 2, HAVcr-2, T-cell immunoglobulin and mucin domain-containing protein 3, T-cell immunoglobulin mucin receptor 3, T-cell membrane protein 3, TIMD-3, TIM-3

3 Images
Flow Cytometry - Anti-TIM 3 antibody (AB47997)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-TIM 3 antibody (AB47997)

Flow cytometric analysis of paraformaldehyde fixed MCF7 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10µg/mL) followed by Alexa Fluor 488 secondary antibody (1µg/mL). IgG control : Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-TIM 3 antibody (AB47997)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-TIM 3 antibody (AB47997)

Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing nuclear and plasma membrane staining. The nuclear stain is DAPI (blue). Negative control : Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).

Western blot - Anti-TIM 3 antibody (AB47997)
  • WB

Supplier Data

Western blot - Anti-TIM 3 antibody (AB47997)

Lysate in RIPA buffer. Detected by chemiluminescence.

Lane 1:

Western blot - Anti-TIM 3 antibody (ab47997) at 0.1 µg/mL

Lane 2:

Western blot - Anti-TIM 3 antibody (ab47997) at 0.5 µg/mL

Lane 1:

A549 cell lysate at 35 µg

Lane 2:

HepG2 cell lysate at 35 µg

false

Key facts

Host species

Goat

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt, ICC/IF

applications

Immunogen

Synthetic Peptide within Human HAVCR2 aa 200-250. The exact immunogen used to generate this antibody is proprietary information.

Q8TDQ0

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-1 µg/mL", "WB-species-notes": "<p>1 hour primary incubation is recommended for this product.</p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "10 µg/mL", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "10 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Primates": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Storage buffer
pH: 7.3 Preservative: 0.02% Sodium azide Constituents: Tris buffered saline, 0.5% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TIM-3 also known as T cell immunoglobulin and mucin-domain containing-3 or HAVCR2 is a protein involved in immune regulation. It possesses an approximate mass of 35 kDa. TIM-3 is expressed on various immune cells including T cells NK cells and dendritic cells especially after activation. The expression level often changes in response to inflammatory conditions suggesting its role in modulating immune responses.
Biological function summary

TIM-3 functions as a checkpoint inhibitor impacting immune cell activity. It is not part of a larger physical complex but it modulates immune responses by interacting with its ligands such as Galectin-9 phosphatidylserine and CEACAM1. TIM-3 involvement in downregulating Th1 cell responses shows its necessary role in maintaining immune homeostasis. The protein also acts in regulating tolerance mechanisms and preventing autoimmunity.

Pathways

TIM-3 participation is seen in the immune checkpoint and T cell exhaustion pathways. TIM-3 signaling results in T cell inhibition affecting the PD-1 pathway as well. It shares a relationship with proteins like LAG-3 and PD-1 which are key to immune inhibitory signaling. These interactions depict TIM-3's role in immune tolerance during chronic infections and malignancies.

TIM-3 association with cancer and chronic infections provides insight into therapeutic implications. In cancer TIM-3 contributes to immune evasion often co-expressed with PD-1 leading to T cell exhaustion. In autoimmune diseases TIM-3 modulation may affect disease progression by influencing immune tolerance. Understanding TIM-3's role in these contexts aids in developing targeted therapies such as anti-TIM-3 antibodies to enhance immune responses in cancer while promoting tolerance in autoimmunity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Cell surface receptor implicated in modulating innate and adaptive immune responses. Generally accepted to have an inhibiting function. Reports on stimulating functions suggest that the activity may be influenced by the cellular context and/or the respective ligand (PubMed : 24825777). Regulates macrophage activation (PubMed : 11823861). Inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance (PubMed : 14556005). In CD8+ cells attenuates TCR-induced signaling, specifically by blocking NF-kappaB and NFAT promoter activities resulting in the loss of IL-2 secretion. The function may implicate its association with LCK proposed to impair phosphorylation of TCR subunits, and/or LGALS9-dependent recruitment of PTPRC to the immunological synapse (PubMed : 24337741, PubMed : 26492563). In contrast, shown to activate TCR-induced signaling in T-cells probably implicating ZAP70, LCP2, LCK and FYN (By similarity). Expressed on Treg cells can inhibit Th17 cell responses (PubMed : 24838857). Receptor for LGALS9 (PubMed : 16286920, PubMed : 24337741). Binding to LGALS9 is believed to result in suppression of T-cell responses; the resulting apoptosis of antigen-specific cells may implicate HAVCR2 phosphorylation and disruption of its association with BAG6. Binding to LGALS9 is proposed to be involved in innate immune response to intracellular pathogens. Expressed on Th1 cells interacts with LGALS9 expressed on Mycobacterium tuberculosis-infected macrophages to stimulate antibactericidal activity including IL-1 beta secretion and to restrict intracellular bacterial growth (By similarity). However, the function as receptor for LGALS9 has been challenged (PubMed : 23555261). Also reported to enhance CD8+ T-cell responses to an acute infection such as by Listeria monocytogenes (By similarity). Receptor for phosphatidylserine (PtSer); PtSer-binding is calcium-dependent. May recognize PtSer on apoptotic cells leading to their phagocytosis. Mediates the engulfment of apoptotic cells by dendritic cells. Expressed on T-cells, promotes conjugation but not engulfment of apoptotic cells. Expressed on dendritic cells (DCs) positively regulates innate immune response and in synergy with Toll-like receptors promotes secretion of TNF. In tumor-imfiltrating DCs suppresses nucleic acid-mediated innate immune repsonse by interaction with HMGB1 and interfering with nucleic acid-sensing and trafficking of nucleid acids to endosomes (By similarity). Expressed on natural killer (NK) cells acts as a coreceptor to enhance IFN-gamma production in response to LGALS9 (PubMed : 22323453). In contrast, shown to suppress NK cell-mediated cytotoxicity (PubMed : 22383801). Negatively regulates NK cell function in LPS-induced endotoxic shock (By similarity).
See full target information HAVCR2

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational medicine 23:1056 PubMed41053808

2025

A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model.

Applications

Unspecified application

Species

Unspecified reactive species

Liying Song,Sumin Tang,Xuelei Pi,Yuanyuan Yan,Chenxi Hu,Liang Liu,Hongna Chen,Yating Zhang,Shishi Liu,Dan Yu,Chengkai Yin,Tianyan Liu,Xu Li,Deshan Li,Zhenzhong Wang,Wei Zhu,Kaiyuan Hui,Zhihang Liu,Xiaodong Jiang

MedComm 6:e70311 PubMed40761479

2025

Nanoparticle-Delivered siRNA Targeting NSUN4 Relieves Systemic Lupus Erythematosus through Declining Mitophagy-Mediated CD8+T Cell Exhaustion.

Applications

Unspecified application

Species

Unspecified reactive species

Bincheng Ren,Kaini He,Ning Wei,Shanshan Liu,Xiaoguang Cui,Xin Yang,Xiaojing Cheng,Tian Tian,Ru Gu,Xueyi Li

iScience 25:105329 PubMed36325060

2022

Cancer cell intrinsic TIM-3 induces glioblastoma progression.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Guo,Shuai Shen,Gefei Guan,Chen Zhu,Cunyi Zou,Jingyuan Cao,Wen Cheng,Xiaoyan Xu,Juanhan Yu,Zhiguo Lin,Guoli Wang,Ling Chen,Peng Cheng,Anhua Wu

Nature communications 13:1157 PubMed35241678

2022

Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Miyoung Lee,Jamie A G Hamilton,Ganesh R Talekar,Anthony J Ross,Langston Michael,Manali Rupji,Bhakti Dwivedi,Sunil S Raikar,Jeremy Boss,Christopher D Scharer,Douglas K Graham,Deborah DeRyckere,Christopher C Porter,Curtis J Henry

OncoTargets and therapy 13:9785-9795 PubMed33061457

2020

MiRNA505/NET1 Axis Acts as a CD8 T-TIL Regulator in Non-Small Cell Lung Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Pengyuan Zhu,Zhenchuan Liu,Haitao Huang,Chongjun Zhong,Yongxin Zhou

Cancer cell international 20:325 PubMed32699524

2020

SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Li Zhang,Sijuan Tian,Minyi Zhao,Ting Yang,Shimin Quan,Qing Yang,Lihua Song,Xiaofeng Yang

Translational oncology 13:100770 PubMed32298986

2020

Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Meijun Zheng,Lingyu Yu,Juanjuan Hu,Zongliang Zhang,Haiyang Wang,Dan Lu,Xin Tang,Jianhan Huang,Kunhong Zhong,Zeng Wang,Yisong Li,Gang Guo,Shixi Liu,Aiping Tong,Hui Yang

The Annals of thoracic surgery 109:1551-1557 PubMed31987829

2020

Significance of TIM-3 Expression in Resected Esophageal Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yuhuan Zhao,Donglai Chen,Wenjia Wang,Ting Zhao,Junmiao Wen,Fuquan Zhang,Shanzhou Duan,Chang Chen,Yonghua Sang,Yongsheng Zhang,Yongbing Chen

Cancer immunology research 7:1175-1187 PubMed31160277

2019

CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Shingo Maeda,Kohei Murakami,Akiko Inoue,Tomohiro Yonezawa,Naoaki Matsuki

Scientific reports 5:9013 PubMed25757669

2015

Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface.

Applications

IHC

Species

Unspecified reactive species

SongCun Wang,ChunMei Cao,HaiLan Piao,YanHong Li,Yu Tao,XiaoMing Zhang,Di Zhang,Chan Sun,Rui Zhu,Yan Wang,MinMin Yuan,DaJin Li,MeiRong Du
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com